Characteristics | Before matching | Â | After matching | Â | ||
---|---|---|---|---|---|---|
 | MIE | RAMIE | P value | MIE | RAMIE | P value |
No. of patients (%) | 43 | 43 | Â | 26 | 26 | Â |
Median age: years (range) |  68(50–78) | 65(47–78) | 0.472 | 67.5(50–76) | 66(47–77) | 0.832 |
<65 / 65–75 / >75 | 16(37.2)/ 25(58.1)/2(4.7) | 21(48.8)/19(44.2)/3(7.0) |  | 9(34.6)/16(61.5)/1(3.8) | 9(34.6)/15(57.7)/2(7.7) |  |
Sex | Â | Â | 0.750 | Â | Â | 0.574 |
 Male / Female | 37(86.0)/6(14.0) | 38(88.4)/5(11.6) |  | 23(88.5)/3(11.5) | 24(92.3)/2(7.7) |  |
BMI | 20.7(16–29) | 21.7(18–28) | 0.830 | 20.8(15.7–28.8) | 23.0(18.1–28.3) | 0.376 |
 <18.5 / 18.5 < BMI < 25 / >25 | 6(14.0)/32(74.4)/5(11.6) | 5(11.6)/33(76.7)/5(11.6) |  | 4(15.4)/19(73.1)/3(11.5) | 3(11.5)/18(69.2)/5(19.2) |  |
Smoking (Brinkman Index) | Â | Â | 0.791 | Â | Â | 0.587 |
 None / <400 / >400 | 9(20.9)/2(4.7)/32(74.4) | 8(18.6)/2(4.7)/33(76.7) |  | 4(15.4)/0(0)/ 22(84.6) | 5(19.2)/1(3.8)/20(76.9) |  |
Alcohol | Â | Â | 0.301 | Â | Â | 1.000 |
 None / Opportunity / Habitual | 4(9.3)/9(20.9)/30(69.8) | 3(7.0)/5(11.6)/35(81.4) |  | 3(11.5)/3(11.5)/20(76.9) | 3(11.5)/3(11.5)/20(76.9) |  |
ASA | Â | Â | 0.466 | Â | Â | 0.381 |
 1 / 2 / 3 | 13(30.2)/27(62.8)/3(7.0) | 17(39.5)/23(53.5)/3(7.0) |  | 11(42.3)/14(53.8)/1(3.8) | 8(30.8)/16(61.5)/2(7.7) |  |
Myocardial infarction | 0(0) | 1(2.3) | 0.323 | 0(0) | 0(0) | - |
Heart failure | 0(0) | 1(2.3) | 0.323 | 0(0) | 0(0) | - |
Cerebrovascular disease | 2(4.7) | 3(7.0) | 0.650 | 1(3.8) | 2(7.7) | 0.574 |
Liver disease | 1(2.3) | 0(0) | 0.323 | 0(0) | 0(0) | - |
Diabetes without chronic complications | 4(9.3) | 2(4.7) | 0.403 | 2(7.7) | 2(7.7) | 1.000 |
Tumor Location | Â | Â | 0.617 | Â | Â | 0.559 |
 Upper / Middle / Lower third | 5(11.6)/16(37.2)/22(51.2) | 2(4.7)/19(44.2)/22(51.2) |  | 3(11.5)/11(42.3)/12(46.2) | 2(7.7)/10(38.5)/14(53.8) |  |
Histology | Â | Â | 0.650 | Â | Â | 0.574 |
 SCC / Adeno | 40(93.0)/3(7.0) | 41(95.3)/2(4.7) |  | 25(96.2)/1(3.8) | 24(92.3)/2(7.7) |  |
Clinical T factor | Â | Â | 0.002 | Â | Â | 0.381 |
 1b / 2 / 3 | 19(44.2)/8(18.6)/16(37.2) | 31(72.1)/8(18.6)/4(9.3) |  | 15(57.7)/6(23.1)/5(19.2) | 18(69.2)/4(15.4)/4(15.4) |  |
Clinical N factor | Â | Â | 0.085 | Â | Â | 0.032 |
 0 / 1 / 2 | 35(81.4)/8(18.6)/0(0) | 29(67.4)/12(27.9)/2(4.7) |  | 24(92.3)/2(7.7)/0(0) | 18(69.2)/7(26.9)/1(3.8) |  |
Clinical TNM stage | Â | Â | 0.139 | Â | Â | 0.802 |
 I / II / III | 18(41.9)/19(44.2)/6(14.0) | 23(53.5)/18(41.9)/2(4.7) |  | 15(57.7)/9(34.6)/2(7.7) | 14(53.8)/10(38.5)/2(7.7) |  |
Preoperative therapy | 6(14.0) | 2(4.7) | 0.010 | 2(7.7) | 2(7.7) | 1.000 |
 None / NAC (FP) / NAC (FP) RT | 21(48.8)/14(32.6)/8(18.6) | 29(67.4)/11(25.6)/3(7.0) |  | 18(69.2)/5(19.2)/3(11.5) | 18(69.2)/5(19.2)/3(11.5) |  |